COMPANY
SHENZHEN JYMED TECHNOLOGY CO LTD
SHENZHEN JYMED TECHNOLOGY CO LTD: API manufacturer for Degarelix, Liraglutide, Oxytocin, Semaglutide, Sermorelin, Teriparatide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Degarelix | DMF 33550, type II, active, submitted 2019-02-21 Regulator FDA drug master file list |
|---|---|
| Liraglutide | DMF 34171, type II, active, submitted 2019-09-27 Regulator FDA drug master file list |
| Oxytocin | DMF 35432, type II, active, submitted 2020-12-29 Regulator FDA drug master file list |
| Semaglutide | DMF 36009, type II, active, submitted 2022-05-04 Regulator FDA drug master file list |
| Semaglutide | DMF 41090, type II, active, submitted 2025-01-17 Regulator FDA drug master file list |
| Semaglutide | DMF 41170, type II, active, submitted 2025-01-08 Regulator FDA drug master file list |
| Semaglutide | DMF 42519, type II, active, submitted 2026-02-05 Regulator FDA drug master file list |
| Sermorelin | DMF 44325, type II, active, submitted 2026-06-29 Regulator FDA drug master file list |
| Teriparatide | DMF 41169, type II, active, submitted 2025-01-06 Regulator FDA drug master file list |
| Tirzepatide | DMF 40115, type II, active, submitted 2024-07-18 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.